STAT Plus: Pharmalittle: Senators propose a new agency to control drug costs; FDA panel backs Amarin fish-oil pill
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is a bit different this time around, since we will be headed toward an out-of-town venue in preparation for a panel appearance (and this means we will have a substitute for us on Monday). And what about you? There is still time to enjoy the autumn, so perhaps a drive in the country is in order. You could also look ahead to the upcoming holiday season and decide where to go, whom to see, and what to do. Or you could engage in a new sport and ponder the meaning of quid pro quo. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon.
Sen. Cory Booker (D-N.J.) and Sen. Bernie Sanders (I-Vt.) introduced a bill that would create a new federal agency focused on controlling the costs of prescription drugs, The Hill reports. The Prescription Drug Affordability and Access Act would form the Bureau of Prescription Drug Affordability and Access. One of the main tenets of the proposal is that if a drug company did not comply with the regulations, it would void exclusivity protections, allowing other companies to produce generic copies of a drug.